Navigation Links
Collagen Matrix, Inc. Receives FDA 510(k) Clearance for TenoMend(TM) Collagen Tendon Wrap for the Management and Protection of Tendon Injuries

FRANKLIN LAKES, N.J., May 27 /PRNewswire/ -- Collagen Matrix, Inc. announced today that it has received the United States Food and Drug Administration's 510(k) clearance of its TenoMend(TM) Collagen Tendon Wrap indicated for the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue.

TenoMend(TM) Collagen Tendon Wrap is a resorbable type 1 collagen matrix that provides a non-constricting encasement for injured tendons. TenoMend(TM) Collagen Tendon Wrap is designed to be an interface between the tendon and tendon sheath or the surrounding tissue. When hydrated, TenoMend(TM) Collagen Tendon Wrap is a conformable, nonfriable, self-curling collagen sheet designed for easy placement under, around or over the injured tendon. The patented self-curling wrap design offers the ability to implant with minimal suturing. The device provides a protected environment and gliding surface of the sheath for tendon healing.

In trauma cases, fractures and injuries of bones in the extremities typically result in injury of the associated soft tissue such as tendon and peripheral nerves. Tendon scarring can often occur as a result of tendon repair. When tendon scarring occurs, other structures such as joints may lose normal range of motion.

Collagen Matrix's portfolio of orthopaedic products now includes solutions for bone, tendon, and peripheral nerve repair. With Collagen Matrix's OssiGuide(TM) Cancellous Granules, OssiMend(TM) and OssiMend(TM) Putty Mineral-Collagen Composites, OssiPatch(TM) Bone Healing Protective Sheet, NeuroMatrix(TM) Collagen Nerve Conduit, Neuroflex(TM) Flexible Collagen Nerve Conduit, NeuroMend(TM) Collagen Nerve Wrap and TenoMend(TM) Collagen Tendon Wrap, the surgeon is equipped with the products needed to repair a complex injury.

The results of an animal flexor tendon repair study using TenoMend(TM) Collagen Tendon Wrap demonstrated the ease of implantation with the tendon's return to full range of motion comparable to normal unsevered tendons. The controls in which severed tendons were repaired but not wrapped, demonstrated statistically significant reduction in range of motion. TenoMend(TM) Collagen Tendon Wrap was successful in providing a protective environment for tendon repair.

"We are committed to providing the surgical community with a full line of products to address complicated orthopaedic injuries involving hard and soft tissues. TenoMend(TM) Collagen Tendon Wrap is the first in a series of tendon repair products under development," said Shu-Tung Li, Ph.D., Founder and CEO of Collagen Matrix. "We are currently exploring potential product marketing and distribution opportunities for worldwide distribution of TenoMend(TM) Collagen Tendon Wrap, which is available immediately," he added.

Collagen Matrix, Inc. is a leader in the design and engineering of collagen- and mineral-based extracellular matrices for tissue and organ repair and regeneration. Since its inception in 1997, the Company has received many government grants for the development of collagen-based matrix products in the areas of neurological, vascular, urological, and orthopaedic tissue regeneration applications. The Company currently manufactures collagen- and mineral-based finished medical devices in the areas of neurosurgery, oral surgery, orthopedic-spine surgery, and wound care. More information about the Company can be found at


Peggy Hansen, RAC

Sr. Director, Clinical, Regulatory,

and Quality Assurance

Tel: 201-405-1477

Fax: 201-405-1355

SOURCE Collagen Matrix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Galderma Completes Acquisition of CollaGenex
2. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
3. Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications
4. TEI Biosciences Launches SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction
5. Jarrow Formulas Launches New Products Featuring BioCell Collagen II(R)
6. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
7. BMP Sunstone Receives Import Drug License (IDL) from SFDA
8. Nikon Instruments Receives Record Number of Entries for Nikon Small World
9. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. febit Receives U.S. Patent for Microfluidic Extraction Method
11. Prime Therapeutics Receives VIPPS Accreditation
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... , November 25, 2015 ... Research Report is a professional and in-depth study ...      (Logo: ) , ... of the industry including definitions, classifications, applications and ... provided for the international markets including development trends, ...
(Date:11/24/2015)... FAR HILLS, N.J. (PRWEB) , ... November 24, 2015 , ... ... University, as the recipient of the 2016 USGA Green Section Award. Presented annually since ... of golf through his or her work with turfgrass. , Clarke, of ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
Breaking Biology Technology:
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig Venter ... titled, "DNA Synthesis and Biosecurity: Lessons Learned and Options ... of Health and Human Services guidance for synthetic biology ... --> --> ... has the potential to pose unique biosecurity threats. It ...
(Date:10/29/2015)... 2015 NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... a leading marketplace to discover and buy innovative ... wallet on StackSocial for this holiday season.   ... "Company"), a biometric authentication company focused on the ...
Breaking Biology News(10 mins):